Weight Loss — Pipeline

The premise

The mechanism we're betting on.

Metabolic-rate, appetite-axis, and adipose-tissue inflammation triplet. Designed as a comparator and adjunct to GLP-1 standard of care — not a competitor but a stack-improver. The full mechanism map — including compound list, dose escalation, pre-specified biomarker thresholds, and the cross-walk modifiers used when re-fitting blends from related indications — is part of the gated methodology pack.Gated

RWE — real-world public landscape

What the rest of the world is doing.

Numbers below are surfaced by Atlas Bio's ClinicalTrials.gov and PubMed RWE pipelines, run against the Weight Loss indication. Counts are industry-wide trials registered on ClinicalTrials.gov, not Atlas Bio studies. Methodology →

RWE refreshed 2026-05-12

Phase I (B1/B2)

292

trials

Phase II (B3)

366

trials

Phase III (B4)

359

trials

Phase IV (B5)

326

trials

Top public trials by enrollment

NCT03574597 · Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity · Novo Nordisk A/S · n=17,604 · PHASE3 · COMPLETED

NCT00317707 · Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk · Mario Negri Institute for Pharmacological · n=12,513 · PHASE3 · COMPLETED

NCT00234832 · A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients · Abbott · n=10,777 · PHASE3 · COMPLETED

Recent published clinical evidence

Early Nutritional Education in the Prevention of Childhood Obesity. · PMID 34207231 · International journal of environmental research and public h · 2021
Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis o · PMID 38755195 · Nutrition & diabetes · 2024
Healthy nutrition environments: concepts and measures. · PMID 15895534 · American journal of health promotion : AJHP · 2005

Pre-registered predictions

Locked before readout.

Predictions for this study are SHA-256 locked before any readout. Pre-registration covers target engagement, primary endpoint, secondary endpoints, and the falsification criterion. The hash, prediction wording, and timestamp are available to verified clinicians and indication researchers on request.Gated

Methodology pillars used

Same stack, every indication.

M2 · Pre-Registration — SHA-256 locking before readout.
M1 · IBC Reasoning — 19-agent audit (11 core + 8 reasoning nodes).
M3 · Cross-Trial Validation — mechanism-anchored bridging across indications.
M4 · RWE Pipelines — ClinicalTrials.gov, PubMed, FDA, EDGAR feeds (the source of the numbers above).

Want the full Weight Loss protocol?

The abstract above is open. Compound lists, dose escalations, SHA-256-locked prediction documents, agent-network reasoning chains, and trial design specifics are available to verified clinicians, indication researchers, and sponsors under MNDA. Contact management to begin the access request.

Contact management →